Search results for "Vaccines"


 
Results 1 - 10 of about 384 for "Vaccines".
Sort by: Relevance | Newest | Oldest

Monkeypox: 5 key points

An expert panel convened by ACP and Annals of Internal Medicine provided five key takeaways about diagnosing and managing monkeypox.
https://acpinternist.org/archives/2022/11/monkeypox-5-key-points.htm
1 Nov 2022

New COVID-19 vaccines tested, authorization changes in progress for existing vaccines

The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
https://acpinternist.org/weekly/archives/2022/05/10/2.htm
10 May 2022

New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments

The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://acpinternist.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022

Details on recently authorized COVID-19 vaccine

This column reviews recent recalls, alerts, and approvals.
https://acpinternist.org/archives/2022/09/details-on-recently-authorized-covid-19-vaccine.htm
1 Sep 2022

New ACIP Adult Immunization Schedule recommends changes to herpes zoster, pneumococcal, hepatitis B vaccines

The guidelines from the CDC's Advisory Committee on Immunization Practices (ACIP) also include information on COVID-19 vaccines, stressing that it is safe to co-administer them with other vaccines.
https://acpinternist.org/weekly/archives/2022/02/22/2.htm
22 Feb 2022

BiPAP machines, masks recalled

This column reviews recent recalls, alerts, and approvals.
https://acpinternist.org/archives/2022/11/bipap-machines-masks-recalled.htm
1 Nov 2022

Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt

Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://acpinternist.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022

Experts cover common COVID-19 challenges

A recent ACP/Annals of Internal Medicine forum on COVID-19 considered the timing of vaccination, outpatient treatment, and pre-exposure prophylaxis.
https://acpinternist.org/archives/2022/10/experts-cover-common-covid-19-challenges.htm
1 Oct 2022

Hepatitis B vaccine now recommended for adults ages 19 through 59 years

The Advisory Committee on Immunization Practices has changed its guidance to encourage clinicians to offer the vaccine to adult patients, rather than target those with risk factors or wait for it to be requested.
https://acpinternist.org/weekly/archives/2022/04/05/1.htm
5 Apr 2022

New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised

One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://acpinternist.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next